Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
Organizer:

We will be covering the current challenges facing the UK in terms of HIV prevention, care and lessons learned. We will review the potential efficiencies available through use of generics and simpler drug regimens including dual-therapy. We will discuss the increasingly important role of third sector and peer support in a climate of ever-declining public health spending. We will review the simplification of HIV monitoring including cessation of CD4 monitoring. 0700 – 0705 Introduction by the Chairs Professor Chloe Orkin, Barts Health NHS Trust, London Professor Jürgen Rockstroh, University of Bonn, Germany 0705 – 0725 The UK Epidemiology and Cascade Dr Valerie Delpech, Public Health England, UK 0725 – 0745 Prevention: Supporting Generic PrEP Access and Offering Monitoring – Legalities and Practicalities Efficiencies Viewed Through 90:90:90 Dr Nneka Nwokolo, 56 Dean Street, London, UK 0745 – 0805 The England Experience: Commissioning and Prescribing Efficiencies Dr Laura Waters, Mortimer Market Centre, London, UK 0805 – 0815 The Patient’s Perspective Miss Angelina Namiba, Salamander Trust, London, UK 0815 – 0830 Panel Discussion

07:00
MOSA0101
Introduction by the Chairs
Chloe Orkin, United Kingdom
Jürgen Rockstroh, Germany
07:05
MOSA0102
The UK Epidemiology and Cascade
Valerie Delpech, United Kingdom
Slides
07:25
MOSA0103
Prevention: Supporting Generic PrEP Access and Offering Monitoring – Legalities and Practicalities Efficiencies Viewed Through 90:90:90
Nneka Nwokolo, United Kingdom
Slides
07:45
MOSA0104
The England Experience: Commissioning and Prescribing Efficiencies
Laura Waters, United Kingdom
Slides
08:05
MOSA0105
The Patient’s Perspective
Angelina Namiba, United Kingdom
Slides
08:15
MOSA0106
Panel Discussion